JOSÉ LUIS
GONZÁLEZ LARRIBA
Catedrático de universidad
Instituto de Biomedicina de Sevilla
Sevilla, EspañaInstituto de Biomedicina de Sevilla -ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2017
-
Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action
Targeted Oncology, Vol. 12, Núm. 1, pp. 19-35
-
The role of mTOR inhibition as second-line therapy in metastatic renal carcinoma: clinical evidence and current challenges
Expert Review of Anticancer Therapy, Vol. 17, Núm. 3, pp. 217-226